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Abstract 
Purpose: The aim of this study was to determine the effects of inspiratory muscle training (IMT) 
on exercise tolerance, inspiratory muscle fatigue and the perception of dyspnea in asthmatic 
individuals. Methods: Using a matched, double-blind, placebo-controlled design, 15 clinically-
diagnosed asthmatics underwent either 6 wks of inspiratory muscle training (IMT, n=7) 
consisting of 30 breaths twice-daily at 50% maximum inspiratory pressure (PImax), or sham-IMT 
(PLA, n=8) consisting of 60 breaths daily at 15% PImax. Time to the limit of exercise tolerance 
(Tlim) was assessed using constant power-output (70% peak power) cycle ergometery. 
Inspiratory muscle fatigue was determined by comparing the pre- to post-exercise reduction in 
PImax. Dyspnea during the Tlim test was evaluated at 2-min intervals using the Borg CR-10 scale. 
Results: There were no significant changes (p>0.05) in Tlim, inspiratory muscle fatigue, or 
perception of dyspnea in the PLA group following the intervention. In contrast, in the IMT 
group, PImax increased by 28%, and Tlim by 16% (P<0.05). Dyspnea during exercise was also 
reduced significantly by 16% (P<0.05). The exercise induced fall in PImax was reduced from10% 
pre-IMT,  to 6%, post-IMT (P<0.05), despite the longer Tlim. Pulmonary function remained 
unchanged in both the IMT and PLA groups. Conclusion: These data suggest that IMT 
attenuates inspiratory muscle fatigue, reduces the perception of dyspnea, and increases exercise 
tolerance. These findings suggest that IMT may be a helpful adjunct to asthma management that 
has the potential to improve participation and adherence to exercise training in this group. 
However, the perception of breathlessness is also an important signal of bronchoconstriction, and 
thus caution should be exercised if this symptom is abnormally low.  
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INTRODUCTION 
Paragraph Number 1 Asthma is a disease associated with intermittent narrowing of the 
airways in which an individual experiences symptoms such as wheezing, chest tightness, 
coughing, and dyspnea (34). A characteristic of chronic asthma is that airway narrowing can alter 
airway function during exercise, and  reduce the maximal-expiratory flow volume curve (15), 
which can  result in  airflow limitation and reduced exercise capacity (18). 
Paragraph Number 2 Airway obstruction during exercise in asthmatic individuals is 
associated with increased inspiratory muscle work as a consequence of resistance to airflow and 
dynamic hyperinflation of the lung (increased end-expiratory lung volume, [EELV]) (15). The 
elevated work of breathing due to dynamic hyperinflation has been shown to be an important 
predictor of dyspnea in individuals with asthma (19), which is intensified by impairment in the 
contractile properties of the respiratory muscles (22). Increased work of breathing may also 
contribute to an increased risk of inspiratory muscle fatigue (39), which may exacerbate dyspnea 
and reduce exercise tolerance (24). Accordingly, it is reasonable to suggest that increasing the 
strength of the inspiratory muscles in people with asthma who experience increased inspiratory 
muscle work, may reduce the intensity of dyspnea, and improve exercise tolerance.        
Paragraph Number 3 Inspiratory muscle training (IMT) has been shown to improve 
inspiratory muscle strength, exertional dyspnea and exercise tolerance in both healthy people and 
patients with COPD (10, 21). A limited number of studies have evaluated the effect of IMT in 
people with asthma, and have all demonstrated improved inspiratory muscle strength, and 
reduced asthma symptoms, as well as reductions in hospitalizations, absence from school or 
work, medication usage, dyspnea during loaded breathing, and improved pulmonary function 
(35-38). However, the influence of IMT upon exercise tolerance and exertional dyspnea in 
people with asthma currently remains unknown.  
Paragraph Number 4 Therefore, the main aim of the present study was to investigate the 
effect of 6 wks of IMT on exercise tolerance and exertional dyspnea in asthmatic individuals. We 
hypothesized that IMT would:  (1) increase inspiratory muscle strength and attenuate respiratory 
muscle fatigue, (2) reduce the perception of dyspnea, and (3) increase exercise tolerance.  
 
METHODS 
Subjects 
Paragraph Number 5 Fifteen subjects (7 male, 8 female; mean ± SEM age 24 ± 1 yr, 
stature 1.74 ± 0.02 m, body mass 76 ± 4 kg) with physician-diagnosed asthma were recruited to 
the study. All had mild to moderate persistent asthma, with a resting forced expiratory volume in 
1-sec (FEV1) of >70% predicted and were taking physician prescribed maintenance medications. 
All subjects continued with their daily maintenance medications (stable dose) throughout the 
duration of the study (i.e. leukotriene receptor antagonists [LTRAs; N= 5 montelukast 
(Singulair®)]; long-acting ß2-agonists [N = 4,fluticasone propionate (Flovent®) and salmeterol 
(Advair®)]; long-acting ß2-agonists and LTRAs [N = 5 salmeterol (Advair®) and montelukast 
(Singulair®)], while short-acting ß2-agonists were discontinued 12hr prior to exercise testing; all 
medication use throughout the course of the study was recorded.  Subjects were asked to refrain 
from exercising 24hr prior to testing, and to avoid caffeine and alcohol intake during this time 
period. Subjects were asked to maintain a normal diet throughout the duration of the study, and 
to avoid consuming food 2hr prior to exercise. Prior to testing each subject completed a health 
screening questionnaire, and provided written informed consent. All testing procedures and 
informed consent were approved by the Indiana University Human Subjects Review Board. 
Study Design 
Paragraph Number 6 Subjects reported to the laboratory on 4 separate occasions. During 
session 1 they performed a maximal incremental cycling test to determine peak power output 
(PPO). Sessions 2 and 3 were conducted pre-intervention, and consisted of a constant-power 
cycle ergometer test to the limit of tolerance (Tlim) at ~70% PPO (session 2 was for 
familiarization purposes). Session 4 was a repeat of sessions 2 and 3, and was conducted after the 
6-wk intervention period. All tests were separated by at least 48hr and were conducted at a 
similar time of day and under similar environmental conditions.  
Paragraph Number 7 Following baseline measurements, subjects were assigned in a 
double-blind manner to either an inspiratory muscle training group (IMT; n = 7) or placebo 
group (PLA; n=8), and were matched across groups according each subjects’ maximal 
inspiratory mouth pressure (PImax).  
Pulmonary function and maximal inspiratory pressure measurements 
Paragraph Number 8 Pulmonary function was assessed using a calibrated computerized 
pneumotachograph spirometer (Vmax 22, SensorMedics, Yorba Linda, CA) according to 
American Thoracic Society (ATS) recommendations (1), which require each subject to perform 
3 acceptable spirograms, of which FVC, FEV1 and FEF25-75% value may not vary by more than 
10%. The largest value is reported. 
Paragraph Number 9 Maximal inspiratory pressure (PImax) was measured using a 
portable hand-held mouth pressure meter (Micro Medical Ltd, Kent, UK) and used as an index of 
inspiratory muscle strength. All maneuvers were initiated from residual lung volume (RV) and 
were conducted in an upright-seated position. A minimum of 5 maneuvers at 30-sec intervals 
were conducted, with the variability between the best three measurements less than 5% or within 
5cm H2O (40).  Measurements of pre- and post-exercise PImax were conducted prior to and 
following the intervention.  
Exercise Testing 
Paragraph Number 10 Peak power output was determined using a continuous maximal 
incremental ramp test (6Watt / 15-sec) on an electromagnetically braked cycle ergometer (Lode 
Excalibur, Netherlands). The test was terminated when the subject reached the limit of tolerance, 
or failed to maintain a pedaling cadence above 50 rpm. The power at which the subjects 
terminated exercise was defined as the peak power output (PPO). 
Paragraph Number 11 Metabolic and ventilatory data were measured continuously using 
breath-by-breath indirect calorimetry (Vmax 22, SensorMedics, Yorba Linda, CA). Heart rate 
was monitored using a F1 Polar Heart Rate Monitor (Polar, Helsinki, Finland). Arterial oxygen 
saturation (SaO2) was estimated using ear oximetry (model 47201A, Hewlett Packard). The 
oximeter was calibrated using an internal protocol prior to each test, according to the 
manufacturer’s instructions. 
Paragraph Number 12 The data generated from the maximal incremental ramp test 
(PPO) was used to determine the power output for the Tlim. The Tlim test was performed at a 
workload of ~70% PPO until volitional fatigue. During the last 30-sec of each minute, two 
maximum inspiratory capacity (IC) maneuvers (inspiration to maximal lung capacity) were 
performed. End-expiratory lung volume (EELV) was calculated by subtracting the maximum 
inspiratory capacity from the resting force vital capacity (FVC), with values expressed as a 
percentage of FVC. EILV was determined as the sum of EELV and VT (average of 10-20 
breaths). Dyspnea was assessed using the Borg scale (CR-10 scale) at 2-min intervals during the 
Tlim test.  
Training Intervention 
Paragraph Number 13 Inspiratory muscle training was completed using a pressure-
threshold training device (POWERbreathe®, HaB International Ltd., UK). The IMT group 
performed 30 dynamic inspiratory efforts twice daily at a pressure-threshold load of 50% of 
PImax for 6 weeks. This specific protocol has been shown to elicit a number of changes in 
inspiratory muscle function, including strength, power and endurance (3, 27-29) . The PLA 
group performed the training intervention once daily for 6 weeks at a pressure-threshold load 
equivalent to 15% of PImax; this protocol has been shown to exhibit no changes in inspiratory 
muscle function (3, 28). Each breath was initiated from RV, with breathing frequency decreased 
to minimize hyperventilation-induced hypocapnia. 
Paragraph Number 14 Compliance to training was monitored using a pressure sensor 
suspended within the main body of the inspiratory muscle trainer (28). The generation of a 
negative pressure exceeding the set point on the pressure switch caused a count to be registered. 
The cumulative number of pressure threshold changes were recorded and computed into total 
number of breaths. Physical activity diaries were used throughout the duration of the study to 
monitor training volume and intensity. 
Data Analysis 
Paragraph Number 15 Data were analyzed using SPSS version 17.0 statistical software. 
The data were assessed for normality using the Kolmogorov-Smirnov test and Levene’s test was 
used to test for homogeneity of variance between tests.  A one-way repeated measures ANOVA 
was used to analyze within group changes over time during the Tlim test. A Mauchly’s test was 
conducted to determine if sphericity was violated. In cases where sphericity was violated, a 
Gieser-Greenhouse correction was applied. Within and between group interactions were 
analyzed using a two-way ANOVA with repeated measures. A Tukey post hoc analysis was 
performed to determine significant differences. Statistical significance was set at p<0.05. Values 
are reported as mean ± SEM.   
 
RESULTS 
Paragraph Number 16  Baseline measurements of pulmonary function (Table 1) were 
within predicted normal limits and were not significantly different (p>0.05) between the IMT 
and PLA groups. All parameters remained unchanged in both groups following the intervention. 
Peak power output achieved during the maximal incremental cycle test was not significantly 
different (p>0.05) between the IMT (250 ± 21 W) and PLA (255 ± 24 W) groups. In addition, 
peak aerobic capacity was not significantly different (p>0.05) between the IMT and PLA groups  
( O2peak, 42.6 ± 2.9 mL.kg
-1
.min
-1
 and 40.2 ± 2.2 mL.kg
-1
.min
-1
, respectively). Subjects adhered 
well to the training intervention with a compliance of 94% and 92% in the IMT and PLA groups, 
respectively. Daily physical activity remained unchanged throughout the intervention period as 
reported by their physical activity logs.  
Maximal Inspiratory Pressure (PImax ) 
Paragraph Number 17 Table 1 shows the mean pre- and post-exercise values for PImax, 
before and after the training intervention. Baseline values for PImax were not significantly 
different (p>0.05) between the IMT and PLA group. Following 6 weeks of training, the IMT 
group demonstrated a significant increase (p<0.05) of 27.7 ± 3.2% in PImax, whilst no change 
(p>0.05) in PImax occurred in the PLA group.  
V
Paragraph Number 18 Prior to the intervention, PImax decreased significantly (p<0.05) 
by 9.6 ± 3.9% and 10.6 ± 3.5% from pre- to post- exercise (index of inspiratory muscle fatigue) 
in both the IMT and PLA groups, respectively. Following IMT, the post-exercise decrease in 
PImax was significantly reduced (p<0.05) to 6.2±4.2% in the IMT group. There was no significant 
change (p>0.05) in inspiratory muscle fatigue in the PLA group following the intervention. 
Exercise Tolerance 
Paragraph Number 19 Prior to the training intervention there was no signficiant 
difference (p>0.05) between groups in the time to the limit of exercise tolerance (Tlim) [8.5 ± 
0.9 min for the IMT group and 9.1 ± 0.9 min for the PLA group]. Following IMT, exercise Tlim 
increased significantly (p<0.05) by 22%, to 10.6 ± 1.5 min in the IMT group. No significant 
change (p>0.05) in the exercise Tlim was observed in the PLA group (Post-PLA, 8.5 ± 1.3 min).  
Metabolic and Ventilatory Responses during exercise 
Paragraph Number 20 The metabolic and ventilatory data from the constant-power Tlim 
test are shown in Table 2. All data are reported in the range of 0-5 min as all subjects sustained 
exercise for a minimum of 5 min both pre- and post- training intervention.  In addition, 
comparisons were made at an end exercise point (isoend), and at a time point during the post-
training Tlim test that corresponded to the pre-training end point (Tbase). Prior to training, there 
were no significant differences (p>0.05) between the IMT and PLA group for any of the 
measured metabolic and ventilatory variables during exercise.  
Paragraph Number 21 Following the training intervention, the PLA group exhibited no 
significant change (p>0.05) in any of the measured metabolic and ventilatory variables. 
However, significant changes (p<0.05) in O2, CO2, and E/ O2 (P<0.05) were observed 
following the training intervention in the IMT group (Table 2). O2 decreased significantly by 
V V V V
V
6% at min 4 and by 12% at the end point of exercise (Fig. 1). Similar changes were also noted 
for CO2, which was significantly lower (p<0.05) at min 4 (9%) and at the end of exercise 
(11%) in the IMT group following the training intervention. All other metabolic and ventilatory 
variables remained unchanged (p>0.05) following training in the IMT group.  
Paragraph Number 22 Figure 2 shows the end-inspiratory lung volume (EILV) and end- 
expiratory lung volume (EELV) responses to exercise, pre- and post- intervention for both the 
IMT (Fig 2a) and PLA (Fig 2b) groups. There was no significant change (p>0.05) in EILV, from 
pre- to post- intervention, in either group at any time point during exercise. However, there was a 
significant decrease (p<0.05) in EELV at minute 5 of exercise in the IMT group following the 
intervention. EELV remained unchanged in the PLA group. The exercising expiratory flow rates 
of both groups are shown in Figure 3. Peak expiratory flow rate (PEFR) and mid-expiratory flow 
rate (MEFR) remained unchanged (p>0.05) in both the IMT and PLA groups following 
intervention.  
Dyspnea 
 Paragraph Number 23 The perception of dypnea during exercise in the IMT and PLA 
group prior to the training intervention was not significantly different (p>0.05) (Fig. 4). Pre- to 
post- IMT, dyspnea was significantly reduced at minute 4 (from 3.7 ± 0.7 to 3.0 ± 0.5) and at the 
end of exercise (from 5.9 ± 0.8 to 5.1 ± 0.9). No significant differences (p<0.05) in dyspnea 
ratings were observed in the PLA group from pre- to post- intervention at any time point during 
exercise.  
DISCUSSION 
Paragraph Number 24. The main findings of the present study are that asthmatic 
individuals performing 6 wks of IMT: 1) increased inspiratory muscle strength and showed 
V
attenuation of exercise-induced inspiratory muscle fatigue and 2) reduced oxygen consumption 
and perception of dyspnea during exercise, and 3) increased Tlim during constant power 
exercise.   
Paragraph Number 25 Inspiratory muscle strength increased by 27% in the present 
study, which is similar in magnitude to that reported previously using pressure-threshold IMT in 
patients with asthma (35, 36). An increase in inspiratory muscle strength following IMT has been 
shown to be associated with an increase in diaphragm thickness (6, 8), and hypertrophy of type I 
and type II muscle fibers of the external intercostals muscles (25). Thus, changes in strength 
reflect structural remodeling within the inspiratory musculature. 
Paragraph Number 26 Impaired inspiratory muscle strength prior to exercise has been 
shown to intensify exertional dyspnea in individuals with asthma (17), and may reduce exercise 
tolerance in these individuals. (24). Consistent with the results of this study, IMT has previously 
been shown to reduce the perception of dyspnea during exercise in healthy individuals (28, 29, 
32) and during pressure threshold inspiratory loading in asthmatic individuals (36). The 
increased inspiratory muscle work associated with increased airway resistance and dynamic 
hyperinflation is an important predictor of dyspnea during bronchoconstriction (19), and may be  
related to a number  of factors such as reduced strength of the inspiratory muscles due to their 
shortened operating length (16), recruitment of additional accessory respiratory muscles (33), 
and increased inspiratory activity during expiration (20). Furthermore, the intensity of dyspnea 
during exercise in asthmatics is associated (r = 0.72) with the degree of bronchoconstriction, 
diffusing capacity of the lung, and inspiratory muscle strength at rest (17).  
Paragraph Number 27 Pulmonary function (FEV1 and FVC) at rest has previously been 
shown to increase by ~12% following 3-6 months of IMT in moderate- to severe- asthmatics (35, 
36). In contrast, neither FEV1 nor FVC changed following 6 weeks of IMT in the present study, 
which may be due to the duration of the training intervention being insufficient, and/or the use of 
individuals with mild asthma, since previous studies have used subjects with moderate- to 
severe- asthma (35, 36). Therefore, our data suggest that the reduction in the perception of 
dyspnea that we observed was most likely due to the increase in inspiratory muscle strength 
following IMT, and not due to changes in lung function. Further, this study supports the presence 
of a negative correlation between change in inspiratory muscle strength and the intensity of 
dyspnea during an inspiratory loading task following IMT (36). Specifically, increasing 
inspiratory muscle strength following IMT would require a smaller percentage of maximal force 
generating capacity to produce the required pressure for a given change in volume, decreasing 
the central motor command and thus reducing the perception of effort (7).  
Paragraph Number 28 Exertional dyspnea, which is one of the symptoms of asthma that 
is associated with impaired exercise tolerance (24), has been shown to be reduced by aerobic 
training (13, 26) and following bronchodilator administration (18). The novel finding of this 
study is that IMT can improve exercise tolerance and reduce the perception of dyspnea in 
recreationally active asthmatic individuals with mild asthma, suggesting a potential role for IMT 
as a complementary intervention in this population. However, it should also be noted that a 
reduction in the perception of dyspnea may be potentially dangerous in the small population of 
asthmatics who have a low perception of dyspnea, and may cause them to underestimate the 
severity of asthmatic exacerbations.  
Paragraph Number 29 Exercise tolerance may be reduced in asthmatics in association 
with expiratory flow limitation and dynamic hyperinflation (increased EELV) during exercise 
(18). Participants in the present study demonstrated a progressive increase in EELV with 
increasing exercise duration; however, participants in the IMT group showed a tendency towards 
a reduction in the degree of hyperinflation during the first 5 minutes of exercise following IMT, 
and a significant attenuation at 5 minutes. There was a similar tendency for EILV to be reduced, 
and for VT to remain unchanged in the IMT group, post-intervention. Previous research has 
shown that an increase in EELV during voluntary hyperpnea increased the elastic work of 
breathing and elevated the oxygen cost of ventilation (5). Thus, the reduction in the extent of 
hyperinflation demonstrated in the present study may be associated with a lower level of 
inspiratory muscle work, and is consistent with the reduction in the oxygen consumption during 
exercise that was observed in the IMT group post-intervention. 
Paragraph Number 30 Exercise in individuals with chronic asthma can induce airway 
narrowing that can modify airway function during exercise, thereby reducing the maximal-flow 
volume loop, and consequently the ventilatory capacity and ventilatory reserve (15). Emerging 
evidence suggests that the paradoxical bronchoconstriction occurring in airways of people with 
asthma after deep inhalation (DI) is normalized when the DI occurs against a pressure threshold 
load (14). The modification of airway caliber following DI may be explained by the slow rate 
cross bridge cycling in airway smooth muscle, termed the ‘latched state’, which results in 
increased smooth muscle stiffness (9, 12). It has been suggested that the chronic application of 
pressure-threshold loading may exert a beneficial influence upon airway smooth muscle by 
releasing it from its ‘latched state’ (14). Thus, it is possible that IMT may elicit subtle 
improvements in airway diameter and airflow limitation during exercise, thereby reducing 
dynamic hyperinflation and increasing exercise capacity. The fact that peak and mean inspiratory 
flow rates were unchanged post-IMT (Figure 3), yet EELV was slightly reduced (Figure 2), 
supports this notion, but further investigation is necessary to confirm this hypothesis. 
Paragraph Number 31 The finding that the oxygen cost of constant-power submaximal 
cycling exercise at ~70%  ̇O2max was reduced following IMT is consistent with previous studies 
that have also shown a reduction in  ̇O2 during running (23), cycling (2), and in hypoxia (6) after 
IMT in healthy individuals. A reduced  ̇O2 may relate in part to improvements in respiratory 
muscle efficiency, which can be quantified as the additional oxygen consumption required for a 
given increase in ventilatory work (4). During incremental inspiratory loading, respiratory 
muscle efficiency has been shown to be lower in asthmatics compared to healthy individuals, and 
improved following the administration of a bronchodilator, which resulted in a reduction in 
hyperinflation and a corresponding increase of inspiratory muscle strength. Specifically, an 
increase in inspiratory muscle strength following IMT may decrease the relative intensity for a 
given amount of work, resulting in recruitment of fewer muscle fibers or delaying the 
recruitment of accessory respiratory muscles, thereby lowering the O2 requirement of the 
respiratory musculature.  Thus, the reduced whole-body  ̇O2 following IMT in the present study 
may relate to changes in inspiratory muscle strength and/or changes in flow resistive work due to 
altered operating lung volumes during exercise. 
Paragraph Number 32 Consistent with previous studies of IMT in healthy people, we 
observed an attenuation of exercise-induced inspiratory muscle fatigue, despite an increase in the 
time to the limit of tolerance (11, 30, 32).  There are two possible explanations for this, 1) 
stronger inspiratory muscles operate at a lower relative intensity post-exercise, which improves 
their fatigue resistance; 2) IMT attenuates the functional weakening of the inspiratory muscles 
that arises due to dynamic hyperinflation, which would otherwise lead to the recruitment of high-
force generating, highly fatigable accessory muscle fibers, which exacerbate the development of 
respiratory muscle fatigue (33). The attenuation of inspiratory muscle fatigue may also have 
contributed to the improvement in exercise Tlim by delaying the onset of the inspiratory muscle 
metaboreflex (31). 
Conclusion 
Paragraph Number 33 This study has shown that 6 weeks of IMT in individuals with 
mild to moderate asthma, significantly increased inspiratory muscle strength, reduced inspiratory 
muscle fatigue, improved exercise tolerance, and reduced the perception of dyspnea during 
cycling exercise at ~70%  ̇O2max to the limit of tolerance. These data suggest that IMT may be a 
helpful adjunct to asthma management and has the potential to improve participation and 
adherence to exercise training in this group. However, it should also be noted that the perception 
of breathlessness is also an important signal of bronchoconstriction, and thus caution should be 
exercised if this symptom is abnormally low.  
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FIGURE LEGENDS 
Figure 1: VO2 response to constant power cycle ergometry to the limit of tolerance for both 
inspiratory muscle training (IMT, Fig. 1a) and placebo groups (PLA, Fig 1b) pre- and post-
intervention (mean ± SEM).  , pre-IMT; , post-IMT; , pre-PLA; , post-PLA. *denotes 
significant difference from pre-intervention (p<0.05), 
†
 denotes significant difference from Tbase 
(p<0.05). 
 
Figure 2: End-inspiratory lung volume (EILV) and end-expiratory lung volume (EELV) 
responses to constant power cycle ergometry to the limit of tolerance for both inspiratory muscle 
training (IMT, Fig. 2a) and placebo groups (PLA, Fig. 2b) pre- and post-intervention (mean ± 
SEM).  , pre-IMT; , post-IMT; , pre-PLA; , post-PLA. *denotes significant difference from 
pre-intervention (p<0.05). 
 
Figure 3: Peak expiratory flow rate (PEFR, Fig. 3a & 3b) and mid-expiratory flow rate  (MEFR, 
Fig. 3c & 3d) responses to constant power cycle ergometry to the limit of tolerance for both 
inspiratory muscle training (IMT) and placebo groups (PLA) pre- and post-intervention (mean ± 
SEM).  , pre-IMT; , post-IMT; , pre-PLA; , post-PLA. 
 
Figure 4: Dyspnea ratings during constant power cycle ergometry to the limit of tolerance for 
both inspiratory muscle training (IMT) and placebo groups (PLA) pre- and post-intervention 
(mean ± SEM).  , pre-IMT; , post-IMT; , pre-PLA; , post-PLA. *denotes significant 
difference from pre-intervention (p<0.05). 
    
    
    
    

 Table 1: Pulmonary function and inspiratory muscle strength 
 IMT PLA 
 Pre Post Pre Post 
Resting pulmonary function     
FVC (L) 4.33 ± 0.26 4.34 ± 0.25 4.58 ± 0.36 4.63 ± 0.36 
% Predicted 95 ± 5 95 ± 5 97 ± 5 98 ± 5 
FEV1 (L) 3.61 ± 0.22 3.63 ± 0.21 3.71 ± 0.26 3.69 ± 0.30 
% Predicted 93 ± 3 93 ± 3 96 ± 3 95 ± 4 
PEFR (L) 7.19 ± 0.50 7.25 ± 0.42 7.40 ± 0.30 7.47 ± 0.38 
% Predicted 89 ± 4 90 ± 4 93 ± 5 92 ± 3 
FEF25-75% (L) 3.58 ± 0.35 3.74 ± 0.39 3.91 ± 0.44 3.94 ± 0.53 
% Predicted 87 ± 9 91 ± 10 93 ± 9 93 ± 11 
Inspiratory muscle strength     
Pre- exercise PImax (cmH20) 114.6 ± 10.1 145.4 ± 11.7** 114.3 ± 10.3 120.6 ± 9.2 
Post- exercise PImax (cmH20) 101.8 ± 6.8* 134.1 ± 8.0* 103.5 ± 11.4* 109.0 ± 8.6* 
Values are mean ± SEM. FVC, forced vital capacity; FEV1, forced expiratory volume in 1 sec; PEFR, peak expiratory flow rate; 
FEF25-75%, forced expiratory flow during 25-75% of vital capacity; PImax, maximal inspiratory pressure. * denotes significant 
difference from pre- to post- exercise (p<0.05); ** denotes significant difference from pre- to post- training (p<0.05). 
 
 
 Table 2: Metabolic and ventilatory responses to constant-power cycling 
 
 
 
 Pre-Training   Post-Training 
 Rest 2min 4min End   Rest 2min 4min Tbase End  
IMT           
V O2 (L.min
-1) 0.30±0.04 1.94±0.18 2.45±0.26 2.93±0.34  0.32 ±0.03 1.85±0.17* 2.28±0.21* 2.32±0.25* 2.58±0.24* 
V O2 (mL.kg
-1.min-1) 4.4±0.3 27.7±2.1 34.8±2.8 41.7±3.9  4.8±0.3 26.5±2.1 32.6±2.4* 36.1±3.1* 36.7±2.9* 
V CO2( L.min
-1) 0.28±0.04 1.94±0.19 2.82±0.30 3.04±0.35  0.31±0.03 1.85±0.20 2.56 0.26* 2.66 0.28* 2.69 0.28* 
V E/ V

O2 
48.0±4.6 29.2±2.3 34.1±2.6 35.4±2.6  44.3±3.1 30.5±1.9 36.1±2.1* 38.8±1.7 39.1±1.9 
V E/ V

CO2 
48.6±3.4 29.2±1.8 29.7±2.2 34.1±2.4  47.2±2.6 30.8±1.3 32.3±1.6 37.0±1.5 37.7±1.7 
V E ( L.min
-1) 
13.9±1.7 55.1±3.6 80.7±5.5 100.7±9.4  14.0±1.3 56.0±4.9 81.5±7.1 97.8±9.9 100.6±9.8 
VT (L) 0.78±0.10 2.08±0.20 2.47±0.25 2.23±0.22  1.04±0.15 1.94±0.14 2.41±0.21 2.21±0.21 2.18±0.22 
FR (breaths.min
-1) 18±2 28±2 36±2 46±3  17±3 30±2 34±2 45±3 47±2 
Ti/TT (%) 44.6±2.9 46.4±1.0 47.3± 1.0 47.7±1.1  40.9±1.9 46.4±1.0 47.6±1.0 47.6±0.6 48.0±0.5 
RER 0.92±0.04 0.99±0.03 1.15±0.02 1.04±0.01  0.98±0.04 0.98±0.05 1.12±0.02 1.05±0.02 1.04±0.02 
HR (bpm) 91.0±4.3 147.7±5.1 162.0±5.1 179.3±4.3  85.3±2.0 147.4±4.4 161.0±4.0 172.9±5.8 175.1±5.1 
SaO2 (%) 95.2±0.6 94.3±0.7 94.6±0.72 94.0±0.5  95.3±0.3 94.8±0.3 93.9±0.5 95.1±0.7 94.4±0.6 
 
Control 
          
V O2 (L.min
-1) 0.32± 0.06 1.84±0.20 2.45± 0.18 2.86±0.23  0.32±0.04 1.83±0.18 2.38±0.19 2.73±0.21 2.74±0.22 
V O2 (mL.kg
-1.min-1) 3.5 0.4 24.3±1.67 30.6±2.0 35.5±2.0  3.6±0.5 23.7±1.6 29.6±1.9 33.3±2.0 33.7±1.9 
V CO2(L.min
-1) 0.28±0.05 1.88±0.21 2.80±0.19 2.88±0.26  0.29 0.04 1.96±0.18 2.71±0.20 2.91±0.21 2.93±0.21 
V E/ V

O2 
41.9±3.0 29.7±2.3 33.7±1.3 35.8±0.8  44.5±3.8 30.6±1.5 35.0±1.2 38.7±1.1 37.1±0.6 
V E/ V

CO2 
47.4±3.1 27.2±2.1 29.8±0.9 36.0±1.5  49.3±4.6 29.8±1.8 31.1±0.8 36.1±1.1 37.3±0.7 
V E (L.min
-1) 
12.6±1.6 50.4±5.9 81.5±3.9 101.9±7.3  13.6±1.1 57.2±3.7 83.2±4.0 104.6±6.6 106.4±7.6 
VT (L) 0.88±0.14 2.18±0.15 2.53±0.14 2.42±0.18  0.86±0.09 2.14±0.16 2.49±0.15 2.31±0.11 2.27±0.12 
FR (breaths.min
-1) 16±1 27±1 34±1 44±2  18±2 28±1 34±1 45±3 47±2 
Ti/TT (%) 42.3±2.9 45.4±1.5 47.8±1.0 49.0±1.1  40.9±2.0 46.8±0.6 47.8±1.0 48.8±1.2 48.3±1.3 
RER 0.90±0.02 1.02±0.05 1.15±0.03 1.04±0.02  0.91±0.03 1.03±0.04 1.15±0.03 1.08±0.02 1.07±0.02 
HR (bpm) 78.2±4.7 148.9±6.8 162.4±6.2 178.4±5.2  85.0±3.3 149.4±5.6 163.9±5.8 176.6±5.3 177.9±4.9 
SaO2 (%) 94.7±0.9 93.9±0.9 93.7±1.1 93.4±1.3  95.0±0.6 93.9±1.2 93.9±1.0 94.1±0.8 94.4±1 .0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values are mean ± SEM. *denotes significantly different from pre-training (p<0.05). V O2, peak oxygen 
consumption; VE, minute ventilation; VT, tidal volume; FR, breathing frequency; Ti/TT, ratio of 
inspiratory time to total time; RER, respiratory exchange ratio; SaO2, arterial oxygen saturation; end, end 
exercise. 
 
